Small biotechs team up with big partners to manufacture drugs

(American Chemical Society) Many of the most promising new molecules to treat diseases come from smaller biotechnology firms, which often lack resources to scale up production when it's time for their drugs to go to large-scale clinical trials or the market. Now, a cover story in Chemical& Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, describes how small biotechs are teaming up with big pharmaceutical outsourcing firms to manufacture their molecules.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news